227 related articles for article (PubMed ID: 36977205)
21.
Huang S; Chen B; Qiu P; Yan Z; Liang Z; Luo K; Huang B; Jiang H
Transl Cancer Res; 2023 Jun; 12(6):1588-1601. PubMed ID: 37434681
[TBL] [Abstract][Full Text] [Related]
22. METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.
Meng QZ; Cong CH; Li XJ; Zhu F; Zhao X; Chen FW
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4328-4336. PubMed ID: 32373970
[TBL] [Abstract][Full Text] [Related]
23. Chinese Ecliptae herba (Eclipta prostrata (L.) L.) extract and its component wedelolactone enhances osteoblastogenesis of bone marrow mesenchymal stem cells via targeting METTL3-mediated m6A RNA methylation.
Tian S; Li YL; Wang J; Dong RC; Wei J; Ma Y; Liu YQ
J Ethnopharmacol; 2023 Aug; 312():116433. PubMed ID: 37004744
[TBL] [Abstract][Full Text] [Related]
24. N6-Methyladenosine Methyltransferase METTL3 Alleviates Diabetes-Induced Testicular Damage through Modulating TUG1/Clusterin Axis.
Tian Y; Xiao YH; Sun C; Liu B; Sun F
Diabetes Metab J; 2023 Mar; 47(2):287-300. PubMed ID: 36653890
[TBL] [Abstract][Full Text] [Related]
25. Methyltransferase-like 3 facilitates the stem cell properties of esophageal cancer by upregulating patched homolog 1 via N6-methyladenosine methylation.
Liang H; Fang C; Zhang L
Am J Physiol Cell Physiol; 2023 Sep; 325(3):C770-C779. PubMed ID: 37575058
[TBL] [Abstract][Full Text] [Related]
26. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
[TBL] [Abstract][Full Text] [Related]
27. METTL3 promotes the growth and metastasis of pancreatic cancer by regulating the m6A modification and stability of E2F5.
Tang Y; Gao G; Xia WW; Wang JB
Cell Signal; 2022 Nov; 99():110440. PubMed ID: 35985439
[TBL] [Abstract][Full Text] [Related]
28. KDM1A-mediated upregulation of METTL3 ameliorates Alzheimer's disease via enhancing autophagic clearance of p-Tau through m6A-dependent regulation of STUB1.
Tang Z; Cao J; Yao J; Fan X; Zhao J; Zhao M; Duan Q; Han B; Duan S
Free Radic Biol Med; 2023 Feb; 195():343-358. PubMed ID: 36587923
[TBL] [Abstract][Full Text] [Related]
29. METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.
Ye K; Li L; Wu B; Wang D
Genes Genomics; 2022 Nov; 44(11):1311-1322. PubMed ID: 36074324
[TBL] [Abstract][Full Text] [Related]
30. METTL3 contributes to renal ischemia-reperfusion injury by regulating Foxd1 methylation.
Meng F; Liu Y; Chen Q; Ma Q; Gu S; Cui R; Cao R; Zhao M
Am J Physiol Renal Physiol; 2020 Nov; 319(5):F839-F847. PubMed ID: 32954854
[TBL] [Abstract][Full Text] [Related]
31. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
Dou X; Wang Z; Lu W; Miao L; Zhao Y
BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
[TBL] [Abstract][Full Text] [Related]
32. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.
Xie H; Yao J; Wang Y; Ni B
Drug Deliv; 2022 Dec; 29(1):1257-1271. PubMed ID: 35467477
[TBL] [Abstract][Full Text] [Related]
33. Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.
Ni WJ; Zhou H; Lu H; Ma NN; Hou BB; Li W; Kong FX; Yu JT; Hou R; Jin J; Wen JG; Zhang T; Meng XM
Clin Transl Med; 2023 Aug; 13(8):e1359. PubMed ID: 37537731
[TBL] [Abstract][Full Text] [Related]
34. N(6)-methyladenosine RNA methyltransferase like 3 inhibits extracellular matrix synthesis of endplate chondrocytes by downregulating sex-determining region Y-Box transcription factor 9 expression under tension.
Xiao L; Hu B; Ding B; Zhao Q; Liu C; Öner FC; Xu H
Osteoarthritis Cartilage; 2022 Apr; 30(4):613-625. PubMed ID: 35007741
[TBL] [Abstract][Full Text] [Related]
35. m6A-related bioinformatics analysis and functional characterization reveals that METTL3-mediated NPC1L1 mRNA hypermethylation facilitates progression of atherosclerosis via inactivation of the MAPK pathway.
Zhang G; Li X; Huang X
Inflamm Res; 2023 Mar; 72(3):429-442. PubMed ID: 36583755
[TBL] [Abstract][Full Text] [Related]
36. Human aortic smooth muscle cell regulation by METTL3 via upregulation of m6A NOTCH1 modification and inhibition of NOTCH1.
Yang J; Fang M; Yu C; Li Z; Wang Q; Li C; Wu J; Fan R
Ann Transl Med; 2023 Aug; 11(10):350. PubMed ID: 37675298
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA SNHG4 remits lipopolysaccharide-engendered inflammatory lung damage by inhibiting METTL3 - Mediated m
Li SX; Yan W; Liu JP; Zhao YJ; Chen L
Mol Immunol; 2021 Nov; 139():10-22. PubMed ID: 34450538
[TBL] [Abstract][Full Text] [Related]
38. METTL3 promotes inflammation and cell apoptosis in a pediatric pneumonia model by regulating EZH2.
Yang Y; Yang X; Wu Y; Fu M
Allergol Immunopathol (Madr); 2021; 49(5):49-56. PubMed ID: 34476922
[TBL] [Abstract][Full Text] [Related]
39. METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells.
Feng Z; Li Q; Meng R; Yi B; Xu Q
J Cell Mol Med; 2018 May; 22(5):2558-2568. PubMed ID: 29502358
[TBL] [Abstract][Full Text] [Related]
40. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
Miao W; Chen J; Jia L; Ma J; Song D
Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]